Pepceuticals

Part of the Biosynth Group since Sept 2023, Pepceuticals Ltd,(est.1998), is a specialist British manufacturer of synthetic peptides. We remain dedicated to supplying the Life Science industry with high-quality custom peptides and antibody manufacturing service. Over the years, Pepceuticals has established a reputation for excellence in the field of peptide synthesis, having developed novel technologies that allow us to prepare complex peptide molecules. We are committed to providing solutions to researchers globally by continuing to increase our development program of large and small synthetic peptide libraries, and enhancing the prospects of obtaining new research candidates. We provide a comprehensive drug development program that allows us to furnish peptides manufactured under cGMP, from milligram to kilogram quantities and to support all aspects of peptide manufacture. Furthermore, we also have an active program to develop generic peptide active substances (API’s) that cover many different disease areas. At Pepceuticals, we operate a stringent Pharmaceutical Quality System which verifies that the products we supply meet or exceed industry standards. Pepceuticals holds an API manufacturing licence as granted by the MHRA (Medicines and Healthcare Products Regulatory Agency) and BSI ISO 2001-2015 accreditation from the British Standards Industry (BSI) for our manufacturing practices. Our Quality Control (QC) team, ensure that our instrumentation, operating/ testing, and staff training are maintained and continually updated to achieve these high standards. Our aim is to deliver all our products in a reliable time frame with a full certificate of analysis and supporting data. We ensure effective project management and good communication with all our clients; from sales to product delivery we aspire to offer a complete solution. We trust that you will enjoy the benefits of working with Pepceuticals, as a reliable, flexible and innovative peptide manufacturer.